Blood tests can provide important clues about how AL amyloidosis is responding to treatment. Learn what key blood test results mean, how your care team uses them to track your disease, and how changes in your results may help guide treatment decisions and next steps in your care.

Siddhartha Ganguly, MD, Carol Cockrell Curran Distinguished Centennial Chair in Hematologic Oncology at Houston Methodist, is a Professor of Clinical Medicine. His practice centers on bone marrow transplantation, cellular therapeutics, and light-chain (AL) amyloidosis associated with plasma cell dyscrasias, while his research emphasizes clinical trials and cellular therapies.